21 March 2018 | News
The Zephyr has shown strength in terms of innovation in products and technologies, leadership in customer value, and speed in response to market needs
Frost & Sullivan recognizes Zephyr Health with the 2018 North American Entrepreneurial Company of the Year Award for its Insights-as-a-Service solution Zephyr IlluminateTM.
Zephyr Health is a privately held company headquartered in San Francisco with offices in London, UK, and Pune, India.
It has the ability to seamlessly combine internal and external data points with publically available healthcare data using a proprietary machine learning (ML) algorithm for real-time commercial insights.
"The company's Zephyr IlluminateTM solution provides pharmaceutical commercial teams—including sales, marketing, and medical affairs teams—with a real-time predictive insights platform, which sets Zephyr Health in a unique and differentiated position within the pharmaceutical analytics space," said Neelotpal Goswami, Senior Industry Analyst.
Each year, Frost & Sullivan presents this award to the company that has demonstrated excellence in devising a strong growth strategy and robustly implementing it.
The recipient has shown strength in terms of innovation in products and technologies, leadership in customer value, and speed in response to market needs.